HK Inno N Corp
195940
Company Profile
Business description
HK Inno N Corp operates in the Ethical Drugs (ETC) and Health & Beauty (H&B) businesses. Key products in the ETC sector include K-Cap, Lovajet, and Akinzio, while key products in the H&B sector include Condition, Hogaesu, and B-Ones. The company operates in two segments: Pharmaceutical division; and Health and Beauty division. It generates maximum revenue from Pharmaceutical division. Geographically, it operates in Domestic and Foreign markets.
Contact
No. 239, Osongsaengmyeong 2-ro
Osong-eup, Heungdeok-gu
Chungcheongbuk-do
Cheongju-si
KORT: +82 3151764000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,703
Stocks News & Analysis
stocks
Wide moat share expects luck to turn
A tough year for jackpots however earnings are expected to normalise.
stocks
ASX share’s growth story intact despite supply constraints
Short term supply challenges but Chinese growth story remains intact.
stocks
ASX healthcare giant rallies despite a fall in profits
Easing investor concerns and signalling a return to growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,269.70 | 13.70 | -0.15% |
| CAC 40 | 8,462.06 | 8.97 | 0.11% |
| DAX 40 | 26,060.96 | 77.92 | 0.30% |
| Dow JONES (US) | 52,759.21 | 703.84 | -1.32% |
| FTSE 100 | 10,770.74 | 22.58 | 0.21% |
| HKSE | 26,009.46 | 310.97 | 1.21% |
| NASDAQ | 26,067.17 | 263.92 | -1.00% |
| Nikkei 225 | 66,016.36 | 200.43 | -0.30% |
| NZX 50 Index | 13,972.66 | 52.84 | 0.38% |
| S&P 500 | 7,641.16 | 66.82 | -0.87% |
| S&P/ASX 200 | 9,058.90 | 6.90 | -0.08% |
| SSE Composite Index | 3,905.20 | 1.48 | 0.04% |